Clinical Trial Update: Effects Of DP-b99 On Neurological Function In Subjects With Acute Ischemic Hemispheric Stroke [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating DP-b99 for neurological outcomes in acute ischemic hemispheric stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Ischemia
• Cerebrovascular Disease
• Stroke

Drugs mentioned

• DP-b99 (DP-b99)

Snippet

Sponsor: D-Pharm Ltd. | Conditions: Brain Ischemia, Stroke | Phase 2 | Status: COMPLETED